Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Opens Proteomics Lab With Australia's Monash University in Malaysia

NEW YORK (GenomeWeb) – Agilent Technologies has announced a partnership with Monash University Malaysia to open a jointly-run laboratory for proteomics, metabolomics, and multi-omics research.

Under the terms of the agreement, Agilent will provide hardware, software, staff training, and technical support for the Integrative Biology Laboratory, which will feature Agilent's iFunnel technology and a 6550 quadrupole time-of-flight liquid chromatograph/mass spectrometer. Agilent will also provide the Australian university's Malaysian campus with early access to new microarray technology and will collaborate with the school to design arrays for its screening and research projects.

"With the Agilent mass spectrometer at its heart, this laboratory will help strengthen our current proteomics, metabolomics and small-molecules research capabilities," Monash Malaysia Professor Dato' Anuar Zaini said in a statement.

The new laboratory expands the partnership between Agilent and Monash, which created a microarray laboratory at the Malaysian campus in 2011. The new lab, which will be housed at the university's Jeffrey Cheah School of Medicine and Health Sciences outside Kuala Lumpur, will conduct workshops and training for local and international scientists.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more